Skip to main content
. 2021 Sep 10;11(9):e520. doi: 10.1002/ctm2.520

FIGURE 7.

FIGURE 7

The blood small EV miR‐335‐5p/miR‐340‐5p was identified as a potential metastasis biomarker and able to reveal the prognosis. (A) The AUC of the ROC curves of the blood small EV miR‐335‐5p for distinguishing between metastasis patients and nonmetastasis patients in the training cohort is displayed. (B) The AUC of the ROC curve of the blood small EV miR‐335‐5p/miR‐340‐5p to differentiate between metastasis patients and nonmetastasis patients in the training cohort is displayed. (C) The distribution is shown as a boxplot for the quotients of the blood small EV miR‐335‐5p/miR‐340‐5p in patients from the training cohort and the test cohort with metastasis and nonmetastasis. (D) The Kaplan–Meier plot on the quotient of the blood small EV miR‐335‐5p/miR‐340‐5p is shown